Structure-destabilizing mutations unleash an intrinsic perforation activity of antiapoptotic Bcl-2 in the mitochondrial membrane enabling apoptotic cell death

Area of Science:

• Molecular Biology
• Cell Death Research
• Protein Structure and Function

Background:

• Bcl-2 and Bax proteins have opposing roles in apoptosis, with Bax forming pores and Bcl-2 inhibiting them.
• Both proteins can adopt similar conformations upon activation by BH3-only proteins, embedding in the mitochondrial outer membrane (MOM).

Purpose of the Study:

• To investigate if destabilizing Bcl-2's structure could transform it into a Bax-like pore-forming protein.
• To explore the potential of manipulating Bcl-2 for cancer therapy.

Main Methods:

• Introducing mutations (e.g., glutamate 152) to reduce Bcl-2 structural stability.
• Assessing apoptosis induction by measuring cytochrome c release in Bax/Bak-deficient cells.
• Utilizing liposomal membranes with mitochondrial lipids and purified proteins to confirm intrinsic perforation activity.

Main Results:

• Mutant Bcl-2 proteins lacking core hydrogen bonds induced apoptosis by releasing cytochrome c.
• This perforation activity was demonstrated to be intrinsic to Bcl-2 and could be activated by BH3-only proteins.
• Bcl-2's conversion to a pro-apoptotic perforator was achieved through molecular manipulation.

Conclusions:

• Antiapoptotic Bcl-2 can be structurally converted into a pro-apoptotic perforator.
• This conversion can be achieved via simple molecular changes or interactions.
• This finding presents a novel strategy for targeting cancer cells resistant to current Bcl-2 therapies.